At a Glance
| Flubromazolam | Baclofen | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 150–250 μg | 20–50 mg |
| Total Duration | — | 2.5–4.8 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Flubromazolam and Baclofen is classified as dangerous. Combined CNS depression; risk of respiratory failure
Flubromazolam, a Depressant, and Baclofen, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 10 documented effects in common, with 1 effects unique to Flubromazolam and 8 unique to Baclofen. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Flubromazolam | Baclofen | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 150–250 μg | 20–50 mg |
| Total Duration | — | 2.5–4.8 hrs |
| Routes | oral | oral |
| Effects |
| 11 documented |
| 18 documented |
| Interaction | Dangerous | |
| Level | Flubromazolam | Baclofen |
|---|---|---|
| Threshold | 50 μg | 5 mg |
| Light | 100–150 μg | 10–20 mg |
| Common | 150–250 μg | 20–50 mg |
| Strong | 250–400 μg | 50–100 mg |
| Heavy | 400 μg | 100 mg |
Flubromazolam
Baclofen
Total: 8 hrs – 14 hrs
Combined CNS depression; risk of respiratory failure